Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin

被引：4

作者：

Suzuki, Yasuhito ^{[1
]}

Tanino, Yoshinori ^{[1
]}

Nikaido, Takefumi ^{[1
]}

Minemura, Hiroyuki ^{[1
]}

Umeda, Takashi ^{[1
]}

Rikimaru, Mami ^{[1
]}

Onuma, Takumi ^{[1
]}

Naito, Shotaro ^{[2
]}

Takiguchi, Yoshinori ^{[3
]}

Tomita, Hikaru ^{[1
]}

Kawamata, Takaya ^{[1
]}

Togawa, Ryuichi ^{[1
]}

Sato, Yuki ^{[1
]}

Uematsu, Manabu ^{[1
]}

Morimoto, Julia ^{[1
]}

Kitakawa, Kadzuhiro ^{[4
]}

Tsukada, Yasuhiko ^{[5
]}

Nakamura, Kiwamu ^{[6
]}

Kanemitsu, Keiji ^{[6
]}

Iseki, Ken ^{[5
]}

Shibata, Yoko ^{[1
]}

机构：

[1] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Japan

[2] Fukushima Med Univ, Dept Gen Internal Med, Fukushima, Japan

[3] Fukushima Med Univ, Dept Diabet Endocrinol & Metab, Fukushima, Japan

[4] Fukushima Prefectural Inst Publ Hlth, Fukushima, Japan

[5] Fukushima Med Univ, Dept Emergency & Crit Care Med, Fukushima, Japan

[6] Fukushima Med Univ, Dept Infect Control, Fukushima, Japan

来源：

INTERNAL MEDICINE | 2021年 / 60卷 / 03期

关键词：

coronavirus disease 2019; COVID-19; intravenous immunoglobulin; severe acute respiratory syndrome-coronavirus-2; acute respiratory distress syndrome; deterioration; COVID-19; MODULATE;

D O I：

10.2169/internalmedicine.6326-20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report a case of severe coronavirus disease 2019 (COVID-19) in which high-dose intravenous immunoglobulin (IVIg) treatment achieved significant clinical improvement of deterioration of pulmonary inflammation after temporary clinical improvement. In the present case, clinical and radiological deterioration occurred despite a decrease in viral load, suggesting that deterioration was caused by reactivation of proinflammatory factors. such as tumor necrosis factor-a and interleukin-6, rather than direct viral effects. IVIg treatment may provide not only immunosuppressive effects but also inhibition of proinflammatory cytoldnes, indicating that treatment including IVIg may be effective by inhibiting cytokine storm in severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection.

引用

页码：457 / 461

页数：5

共 50 条

[41] The effect of High-Dose Vitamin C Treatment for Acute Respiratory Failure Due to Coronavirus Disease Pneumonia on Mortality and Length of Intensive Care Stay: A Retrospective Cohort Study
Coskun, Nurcan
Altinay, Mustafa
Turk, Hacer Sebnem
Peker, Nebia
Islamoglu, Serkan
Cinar, Ayse Surhan
Ozkan, Melis Turkel
MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (01): : 25 - 32
[42] Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
Lee, Jee-Soo
Kim, So Yeon
Kim, Taek Soo
Hong, Ki Ho
Ryoo, Nam-Hee
Lee, Jaehyeon
Park, Jae Hyeon
Cho, Sung Im
Kim, Man Jin
Kim, Young-gon
Kim, Boram
Shin, Ho Seob
Oh, Hyeon Sae
Seo, Myoung-Seock
Gwon, Tae-Rin
Kim, Yeonjae
Park, Jun-Sun
Chin, Bum Sik
Park, Wan Beom
Park, Sung Sup
Seong, Moon-Woo
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E3002 - E3008
[43] Severe acute respiratory syndrome coronavirus 2 variants in patients with coronavirus disease 2019 and environmental sampling from the hospital and market during the coronavirus disease 2019 pandemic in Thailand
Phumisantiphong, Uraporn
Rupprom, Kitwadee
Wongsuk, Thanwa
Manomaipiboon, Anan
Maneerit, Jakravoot
Vimonvattana, Ampan
Chantratita, Wasun
Sensorn, Insee
Hansirisathit, Tonsan
Thongsopa, Wipawee
Phutthanu, Chayanit
Dongphooyao, Sunisa
Thongnak, Chuphong
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (02)
[44] Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
Ren, Xiangge
Zhang, Miaomiao
Zhang, Xiaohan
Zhao, Peidong
Zhai, Wensheng
BMC PEDIATRICS, 2024, 24 (01)
[45] No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019
Pan, Feng
Xiao, Xingyuan
Guo, Jingtao
Song, Yarong
Li, Honggang
Patel, Darshan P.
Spivak, Adam M.
Alukal, Joseph P.
Zhang, Xiaoping
Xiong, Chengliang
Li, Philip S.
Hotaling, James M.
FERTILITY AND STERILITY, 2020, 113 (06) : 1135 - 1139
[46] FAILURE OF REPEATED COURSES OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN TO INDUCE STABLE REMISSION IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
SCHIAVOTTO, C
RUGGERI, M
RODEGHIERO, F
ANNALS OF HEMATOLOGY, 1995, 70 (02) : 89 - 90
[47] A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients
Debs, Rabab
Reach, Pauline
Cret, Corina
Demeret, Sophie
Saheb, Samir
Maisonobe, Thierry
Viala, Karine
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (10) : 864 - 872
[48] Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children
Ancona, KG
Parker, RI
Atlas, MP
Prakash, D
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (07) : 540 - 544
[49] Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence
Tung Hoang
Tho Tran Thi Anh
INFECTION AND CHEMOTHERAPY, 2020, 52 (03) : 317 - 334
[50] TREATMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS BY PROLONGED ADMINISTRATION OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN - REPORT OF 2 CASES
WINDER, A
MOLAD, Y
OSTFELD, I
KENET, G
PINKHAS, J
SIDI, Y
JOURNAL OF RHEUMATOLOGY, 1993, 20 (03) : 495 - 498

← 1 2 3 4 5 →